After working as a medical doctor for 1.5 years, I started my PhD in 2018. My projects focus on identification of biomarkers that could aid in predicting response to neoadjuvant treatment in HER2 positive breast cancer. In addition, I study blood based biomarkers for breast cancer detection and screening.